Regulation of PMP22 Expression in Peripheral Nerve
周围神经中 PMP22 表达的调节
基本信息
- 批准号:9293380
- 负责人:
- 金额:$ 32.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-15 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBinding ProteinsBiological AssayCell Differentiation processCharcot-Marie-Tooth DiseaseChromosomes, Human, Pair 17Clinical TrialsCollaborationsDeteriorationDevelopmentDiseaseDown-RegulationEGR2 geneElementsEnhancersFatigueFoundationsGene DosageGene Expression RegulationGene TargetingGenesGenetic Enhancer ElementGenetic TranscriptionGenomicsGoalsHereditary DiseaseHereditary Motor and Sensory NeuropathiesHumanIndividualInheritedLeadMapsMediatingMolecular TargetMotorMuscular AtrophyMutationMyelinNervous system structurePMP22 genePathway interactionsPatternPeripheralPeripheral NervesPeripheral Nervous System DiseasesPhysiologicalPlayPositioning AttributePreclinical Drug EvaluationProteasome InhibitorRegulationRegulatory ElementRegulatory PathwayRodent ModelRoleSchwann CellsSeriesSiteSterolsTechniquesTestingTransgenic OrganismsTranslatingTranslational ResearchZebrafishafferent nervebasechromatin immunoprecipitationchronic paindesigneffective therapyepigenetic regulationexperiencegenome editingin vivomulticatalytic endopeptidase complexmyelinationmyelinopathynovelnovel therapeuticspublic health relevancetargeted treatmenttooltranscription factor
项目摘要
DESCRIPTION (provided by applicant): Hereditary peripheral neuropathies (also known as hereditary motor sensory neuropathies, HMSN) are among the most common genetic diseases affecting the nervous system. The mildest form of human peripheral neuropathy, Charcot-Marie-Tooth (CMT) disease, causes progressive deterioration of both motor and sensory nerves, muscular atrophy, and chronic pain/fatigue in affected individuals. A majority of inherited peripheral myelinopathies are caused by duplication of a critical myelin gene, Peripheral Myelin Protein 22 (PMP22), which is classified as CMT1A. Since this disorder results from gene dosage effects, achieving a slight (<2-fold) reduction in PMP22 expression would effectively treat this inherited myelinopathy. Recent proof-of-principle studies using candidate compounds to reduce PMP22 expression levels have shown beneficial effects in rodent models of CMT1A. Before such candidate compounds enter clinical trials, it will be critical to achieve a comprehensive understanding of their molecular targets and how they impact PMP22 regulation. Our recent studies of PMP22 regulation have elucidated novel regulatory elements controlled by two major regulators of Schwann cell development-Egr2/Krox20 and Sox10-and the goal of this proposal is to test the function of these elements by using genome editing to delete them in the endogenous PMP22 locus. In addition, we will use zebrafish analysis to elucidate the developmental control of these enhancers. This proposal will also explore the function of cooperating transcription factors that amplify PMP22 expression to the high levels found in myelinating Schwann cells. Finally, using the mechanistic analysis that we have developed, we propose to identify the molecular targets of proteasome inhibitors, which are a candidate treatment for CMT1A as they have been recently identified in a drug screen to lower the expression level of PMP22.
描述(由申请人提供):遗传性周围神经病(也称为遗传性运动感觉神经病,HMSN)是影响神经系统的最常见遗传性疾病之一。最温和形式的人类周围神经病,腓骨肌萎缩症(CMT),在受影响的个体中引起运动和感觉神经的进行性恶化、肌肉萎缩和慢性疼痛/疲劳。大多数遗传性外周髓鞘病是由一个关键的髓鞘基因,外周髓鞘蛋白22(PMP 22),这是分类为CMT1A的重复。由于这种疾病是由基因剂量效应引起的,因此实现PMP 22表达的轻微(<2倍)降低将有效治疗这种遗传性髓鞘病。最近使用候选化合物降低PMP 22表达水平的原理验证研究在CMT1A的啮齿动物模型中显示出有益效果。在这些候选化合物进入临床试验之前,全面了解它们的分子靶点以及它们如何影响PMP 22的调节至关重要。 我们最近对PMP22调控的研究已经阐明了由雪旺细胞发育的两个主要调控因子Egr 2/Krox20和Sox 10控制的新型调控元件,本提案的目标是通过使用基因组编辑来删除内源性PMP22基因座中的这些元件来测试这些元件的功能。此外,我们将使用斑马鱼分析来阐明这些增强子的发育控制。该提案还将探索合作转录因子的功能,这些转录因子将PMP22的表达放大到髓鞘化雪旺细胞中发现的高水平。最后,使用我们已经开发的机制分析,我们建议确定蛋白酶体抑制剂的分子靶点,这是CMT1A的候选治疗,因为它们最近在药物筛选中被确定为降低PMP 22的表达水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John P Svaren其他文献
John P Svaren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John P Svaren', 18)}}的其他基金
Prediction and Validation of Oligodendrocyte Gene Regulatory Network from Multi-Omics
多组学预测和验证少突胶质细胞基因调控网络
- 批准号:
10509768 - 财政年份:2022
- 资助金额:
$ 32.57万 - 项目类别:
Creation of a Schwann Cell Gene Regulatory Network
雪旺细胞基因调控网络的创建
- 批准号:
10581647 - 财政年份:2022
- 资助金额:
$ 32.57万 - 项目类别:
Regulation of PMP22 Expression in Peripheral Nerve
周围神经中 PMP22 表达的调节
- 批准号:
9069615 - 财政年份:2014
- 资助金额:
$ 32.57万 - 项目类别:
Regulation of PMP22 Expression in Peripheral Nerve
周围神经中 PMP22 表达的调节
- 批准号:
8759907 - 财政年份:2014
- 资助金额:
$ 32.57万 - 项目类别:
Epigenetic Regulation of Peripheral Nerve Myelination
周围神经髓鞘形成的表观遗传调控
- 批准号:
8575660 - 财政年份:2013
- 资助金额:
$ 32.57万 - 项目类别:
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 32.57万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别:
Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
$ 32.57万 - 项目类别: